Article Details

Cantor Fitzgerald Weighs in on Axsome Therapeutics, Inc.'s FY2021 Earnings (NASDAQ:AXSM)

Retrieved on: 2021-03-03 12:30:55

Tags for this article:

Click the tags to see associated articles and topics

Cantor Fitzgerald Weighs in on Axsome Therapeutics, Inc.'s FY2021 Earnings (NASDAQ:AXSM). View article details on hiswai:

Excerpt

Neo Ivy Capital Management acquired a new stake in Axsome Therapeutics during the 3rd quarter worth $67,000. Finally, Penserra Capital ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up